Dilation Capital Management LP Makes New $10.01 Million Investment in Amrize Ltd $AMRZ

Dilation Capital Management LP bought a new position in shares of Amrize Ltd (NYSE:AMRZ) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund bought 206,280 shares of the company’s stock, valued at approximately $10,011,000. Amrize accounts for approximately 5.0% of Dilation Capital Management LP’s holdings, making the stock its 10th biggest holding.

A number of other hedge funds have also modified their holdings of AMRZ. Global Retirement Partners LLC acquired a new position in Amrize during the third quarter valued at approximately $48,000. BNP Paribas Financial Markets acquired a new position in shares of Amrize in the 2nd quarter valued at $59,000. Groupe la Francaise bought a new stake in shares of Amrize in the 2nd quarter valued at $60,000. Allianz SE bought a new stake in shares of Amrize in the 2nd quarter valued at $80,000. Finally, ASR Vermogensbeheer N.V. raised its stake in Amrize by 2.3% during the 3rd quarter. ASR Vermogensbeheer N.V. now owns 72,577 shares of the company’s stock worth $3,502,000 after buying an additional 1,661 shares during the period.

Insider Buying and Selling

In other news, CTO Roald Brouwer bought 4,000 shares of the firm’s stock in a transaction that occurred on Friday, October 31st. The stock was acquired at an average cost of $51.77 per share, with a total value of $207,080.00. Following the completion of the purchase, the chief technology officer owned 9,000 shares of the company’s stock, valued at $465,930. This represents a 80.00% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Jaime Hill bought 4,000 shares of the stock in a transaction that occurred on Tuesday, November 4th. The shares were purchased at an average price of $50.69 per share, for a total transaction of $202,760.00. Following the completion of the acquisition, the insider owned 18,101 shares of the company’s stock, valued at $917,539.69. The trade was a 28.37% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought 65,000 shares of company stock valued at $3,399,720 in the last ninety days.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. Wells Fargo & Company increased their price target on Amrize from $57.00 to $58.00 and gave the stock an “overweight” rating in a report on Thursday, October 30th. Oddo Bhf started coverage on Amrize in a research report on Monday, November 3rd. They issued a “neutral” rating for the company. Weiss Ratings raised Amrize from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, January 12th. The Goldman Sachs Group set a $58.00 price target on shares of Amrize in a research note on Monday, January 12th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $70.00 target price on shares of Amrize in a report on Thursday, December 18th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $60.67.

Amrize Trading Up 1.3%

Shares of AMRZ stock opened at $53.60 on Thursday. The company has a fifty day simple moving average of $53.42. The company has a quick ratio of 0.97, a current ratio of 1.45 and a debt-to-equity ratio of 0.38. Amrize Ltd has a 1 year low of $44.12 and a 1 year high of $58.11. The firm has a market cap of $29.65 billion and a price-to-earnings ratio of 29.13.

Amrize (NYSE:AMRZ) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $0.98 EPS for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.03). The firm had revenue of $3.68 billion for the quarter, compared to the consensus estimate of $3.49 billion. Amrize’s quarterly revenue was up 6.6% compared to the same quarter last year.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.